Etanercept
CAS 185243-69-0Biologic
Overview
Etanercept is a biopharmaceutical that inhibits tumor necrosis factor (TNF), which is used to treat autoimmune diseases such as rheumatoid arthritis and psoriasis. It is a fusion protein produced by recombinant DNA technology.
Therapeutic areas
RheumatologyDermatologyGastroenterology
Verified Supplier Partner
Do you supply Etanercept? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.